To assess the toxicity of PU-H71, we compared the expression levels of HSP90, HSP70 (a molecular marker of HSP90 inhibition), and cleaved PARP (a molecular marker of programmed cell death) in normal cells with those in glioma cells (Figure 4). This evidence concerns the gene HSP90AB1 and central nervous system cancer.